Powered by

Stock Monthly: Antibe Therapeutics drops 12% on high volatility Wednesday July 31, 2019 17:00 EDT

Jul 31, 2019 - News Bites Canadian Markets
Board and Executive Moves-Financial Results

CANADIAN MONTHLY STOCK REPORT

Antibe Therapeutics (TSXV:ATE), Canada's 22nd largest Biotechnology company by market cap, traded between an intra-month high of 33.50c and a four-month low of 28.0c. In July its volatility (highest price minus lowest price/lowest price) of 19.6% was 0.69 times average monthly volatility of 28.7%, up from 16.7% in July and 13.8% in May. The share price plummeted 4.0c (or 12.5%) in the past month to close at 28.0c on Wednesday July 31. Compared with the S&P/TSX...